Skip to main content
Fig. 2 | Stem Cell Research & Therapy

Fig. 2

From: Treatment of the bone marrow stromal stem cell supernatant by nasal administration—a new approach to EAE therapy

Fig. 2

Effects of BMSC supernatant treatment on demyelination of the spinal cord and brain. a Demyelination for lumbar spinal cord sections at peak phase by Luxol fast blue staining, magnification × 100. In brain sections, cell infiltration was observed in the injured area of EAE mice (indicate by red arrow), c CD45R-positive B cells, e CD68-positive mononuclear cells, g CD4-positive T cells, i CD86-positive antigen presenting cells, and k Iba-1-positive and m P2ry12-positive microglia, magnification × 200. Percentage area of demyelination in the spinal cord white matter (b) and the number of positive cells per mm2 (d, f, h, j, l, n) calculated by analysis of transverse sections at three separate levels per mouse. Data represent the mean ± SEM of three individual mice per group, **P < 0.01, ***P < 0.001

Back to article page